According to the spokesperson, "The department is engaging with sponsors to address these concerns, where possible, in line with current policy and legislation, including the advice of the independent Pharmaceutical Benefits Advisory Committee." …
Quiet diplomacy as Australia navigates global pricing pressure, but can it work?
April 24, 2026 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Opthea returns to ASX and works to restart eye therapy candidate
June 5, 2026 - - Latest News -
A clear disconnect between the public and private on 'Most Favored Nation' pricing
June 5, 2026 - - Latest News -
New blueprint charts a potential policy path forward on biosimilars
June 4, 2026 - - Latest News -
Officials cite company consultation, system changes, and spending approvals to justify delay
June 4, 2026 - - Latest News -
Novo Nordisk's Marie Krogh Prize returns and crosses the Tasman to back early career women in science
June 4, 2026 - - Latest News -
Study confirms pharmacist led care expands timely access to urinary tract infection treatment and contraception
June 4, 2026 - - BioPharma -
Officials talk down the prospect of MFN impact on the PBS
June 4, 2026 - - Latest News